688136 Kexing Biopharm
- 15.44
- +0.49+3.28%
Kexing Biopharm News
Announcement on Granting Restricted Stocks to Incentive Object
Legal Opinion of Jia Yuan Law Firm of Peking regarding Matters Relating to the Grant of Restricted Stock Incentive Plan of Sinovac Biotech Co., Ltd. in 2024.
List of restricted stock incentive plan recipients (Grant Date) for 2024.
Supervisory Board's verification opinion on the list of incentive recipients for the 2024 restricted stock incentive plan (as of the grant date)
Self-check report on the trading of company stocks by insiders of the 2024 restricted stock incentive plan.
Announcement regarding the achievement of the performance condition for the first attribution period of the restricted stock incentive plan for the company in 2022, and the reserved grant for the second attribution period.
The Supervisory Board's review opinion on the verification of the list of incentive objects who meet the attribution conditions for the first grant period of the 2022 Restricted Stock Incentive Plan and the reserve grant of the second attribution period.
Legal Opinion from Jiayuan Law Firm, Peking, regarding Sinovac Biotech Limited's 2022 Restricted Stock Incentive Plan - First Grant of the Second Vesting Period and Achievement of Vesting Conditions and Invalidation of Part of the Restricted Stock.
Announcement on Invalidating Part of the Restricted Stock Incentive Plan for 2022
Explanation and verification opinions of the announcement of the list of restricted stocks incentive plan beneficiaries for the company's 2024 supervisory board.
2024 Restricted Stock Incentive Plan (Draft) Summary Announcement
Legal opinion of Beijing Jiayuan Law Firm on matters relating to the 2024 Restricted Stock Incentive Plan of Kexing Biopharmaceuticals Co., Ltd.
Supervisory Board's Review Opinions on the Company's 2024 Restricted Stock Incentive Plan (Draft)
2024 Restricted Stock Incentive Plan (Draft)
2024 Restricted Stock Incentive Plan Incentive Recipients List
Announcement on the implementation results of the share repurchase and changes in shares
An indicative announcement on changes in the equity of the controlling shareholder, actual controller, and chairman of the board of directors increased by more than 1%
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Announcement on terminating the issuance of A shares to specific targets in 2023
Announcement on the 2023 Profit Distribution Plan
Analysis
Price Target
No Data
